FDA NDC Directory · JSON-LD · Markdown

Nexviazyme

NDC 58468-0426 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameavalglucosidase alfa-ngpt
Labeler / ManufacturerGenzyme Corporation
Marketing categoryBiologic License Application · App BLA761194
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsAVALGLUCOSIDASE ALFA (100 mg/10mL)
Marketing started20210806
Package count1

External sources

Source: openFDA. Public-domain (CC0).